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Abstract: Diagnosing a peri-prosthetic joint infection (PJI) remains challenging despite the availability
of a variety of clinical signs, serum and synovial markers, imaging techniques, microbiological and
histological findings. Moreover, the one and only true definition of PJI does not exist, which is
reflected by the existence of at least six different definitions by independent societies. These definitions
are composed of major and minor criteria for defining a PJI, but most of them do not include imaging
techniques. This paper highlights the pros and cons of available imaging techniques—X-ray,
ultrasound, computed tomography (CT), Magnetic Resonance Imaging (MRI), bone scintigraphy,
white blood cell scintigraphy (WBC), anti-granulocyte scintigraphy, and fluorodeoxyglucose positron
emission tomography/computed tomography (FDG-PET/CT), discusses the added value of hybrid
camera systems—single photon emission tomography/computed tomography (SPECT/CT), PET/CT
and PET/MRI and reports consensus answers on important clinical questions that were discussed
during the Third European Congress on Inflammation/Infection Imaging in Rome, December 2019.
Keywords: prosthetic joint infection; nuclear imaging; SPECT/CT; PET/CT; radiology
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1. Introduction
The definition and the diagnosis of peri-prosthetic joint infection (PJI) and, more generally,
of implant-related infections, remains a challenge of modern orthopaedics.
In fact, while it seems relatively straightforward to diagnose an infection in the presence of a
draining sinus, an exposed implant, or classical signs and symptoms of an acute inflammatory process,
the differential diagnosis between septic and aseptic implant failure becomes much more challenging
when unspecific clinical symptoms—most often a variable degree of pain and reduced function—are
reported, and laboratory tests yield nonspecific or conflicting results.
Clinical presentations of peri-prosthetic infection are extremely varied, ranging from the acute,
high-grade inflammatory cases to the subclinical low-grade ones [1–3]. The lack of a single accepted
reference test or benchmark makes the evaluation and comparison of the diagnostic accuracy of both
old and new markers, as well as other diagnostic tools, particularly difficult [4–6].
The diagnostic challenge is mirrored by the absence of a universally accepted definition of PJI.
In the last decade, at least six different definitions of PJI have been released by well-respected scientific
societies, including the Musculo-Skeletal Infection Society (MSIS) [7], the Infectious Disease Society
of America (IDSA) [8], two International Consensus Meetings [9–11], the European Bone and Joint
Infection Society (EBJIS) [1], (Table 1) and, more recently, the World Association against Infection in
Orthopaedics and Trauma (WAIOT) (Table 2) [12].
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Table 1. Comparison of the diagnostic criteria adopted by five peri-prosthetic joint infection (PJI) definitions, published from 2011 to 2018 (modified from [13]).
MSIS: Musculo-Skeletal Infection Society; IDSA: Infectious Disease Society of America; ICM: International Consensus Meeting; EBJIS: European Bone and Joint
Infection Society.
Definition Source MSIS 2011 IDSA 2013 ICM 2013 ICM 2018 Proposed EBJIS 2018
Scoring System
1 of the 2 major criteria
OR
≥4 of 6 minor criteria 1
≥1 positive criteria 2
1 of the 2 major criteria
OR
≥3 of 5 minor criteria 3




3–5 possibly infected (“consider further
molecular diagnostics such as
next-generation sequencing”)




1. sinus tract communicating with
the prosthesis;
2. A pathogen is isolated by culture
from at least two separate tissue
or fluid samples obtained from
the affected prosthetic joint
Minor:
(a) Elevated ESR (>30 mm/hr) and




(d) Purulence in the affected joint
(e) Isolation of a microorganism in
one culture of periprosthetic
tissue or fluid
(f) Greater than five neutrophils per
high-power field in five




1. Sinus tract communicating with
the prosthesis
2. Purulence without other
aetiology surrounding
the prosthesis
3. Acute inflammation seen on
histopathological examination of
the periprosthetic tissue





(the growth of a virulent
microorganism
(e.g., Staphylococcus aureus) in a
single specimen of a tissue biopsy
or synovial fluid is also
considered as indicative of a PJI)
Major:
1. A sinus tract communicating
with the joint




(a) Elevated ESR (>30 mm/hr) and
CRP (>100 mg/L for acute
infections; >10 mg/L for
chronic infections)
(b) Elevated synovial fluid WBC
count (>10,000 cells/mL for acute
infections; >3000 cells/mL for
chronic infections) or ++ change
on leukocyte esterase test strip
(c) Elevated PMN% (>90% for acute
infections; >80% for
chronic infections)
(d) Positive histological analysis of
periprosthetic tissue (>5
neutrophils per high-power field
in five high-power fields
observed on periprosthetic tissue
at 400×magnification)
(e) A single positive culture
Major:
1. Sinus tract with evidence of
communication to the joint or
visualization of the prosthesis




(a) Elevated CRP (>100 mg/L for
acute infections; >10 mg/L for
chronic infections) or D-dimer
(unknown threshold for acute
infection; >860 ug/L for chronic
infection) (score 2)
(b) Elevated ESR (no role for acute
infections; >30 mm/hr for chronic
infections) (score 1)
(c) Elevated synovial WBC count
(>10,000 cells/mL for acute
infections; >3000 cells/mL for
chronic infections) OR leukocyte
esterase (++ for acute and
chronic infections) OR positive
alpha-defensin (score 3)
(d) Elevated synovial PMN% (>90%
for acute infections; >70% for
chronic infections) (score 2)
(e) Single positive culture (score 2)
(f) Positive histology (score 3)
(g) Positive intraoperative purulence
(score 3)
1. Purulence around the prosthesis
or sinus tract
2. Increased synovial fluid
leukocyte count (>2000 cells/mL
or >70% granulocytes)
3. Positive histopathology
4. Confirmatory microbial growth
in synovial fluid, periprosthetic
tissue, or sonication culture
(“confirmatory microbial growth in
periprosthetic tissue: if positive in ≥1
specimen in highly virulent organisms
or ≥2 in low virulent pathogens;
sonication culture considered positive
if >50 colony-forming units/mL of
sonication fluid.”)
Abbreviations: ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; PMN: polymorphonuclear leukocytes; WBC: white blood cells; ++: positive. 1 PJI may be present if fewer
than four of these criteria are met. 2 The presence of PJI is possible even if the above criteria are not met. 3 PJI may be present without meeting these criteria. 4 Proceed with caution in
adverse local tissue reaction, crystal deposition disease, slow growing organisms.
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Table 2. World Association against Infection in Orthopaedics and Trauma (WAIOT) proposed definition of peri-prosthetic joint infection (PJI). Pre- and intra-operative
tests, classified according to their sensitivity and specificity and hence their ability to exclude (“rule OUT”) or to confirm (“rule IN”) a PJI. In parenthesis, the reference
cut-off value considered here (modified from [13]).
No Infection Contamination BIM LG-PJI HG-PJI
Clinical presentation
One or more condition(s), other than infection, can cause the
symptoms or the reason for reoperation (e.g., wear debris,
metallosis, recurrent dislocation or joint instability, fracture,
malposition, neuropathic pain)
One or more of the following: otherwise “unexplained” pain,
swelling, stiffness
Two or more of the following:
pain, swelling, redness, warmth,
functio laesa
(Number of positive rule IN
tests)-(number of negative
rule OUT tests)
<0 <0 <0 ≥0 ≥1
Post-operatively confirmed if Negative culturalexamination
One pre- or intra-operative
positive culture, with
negative histology
Positive cultural examination (preferably with antibiofilm techniques) and/or positive histology
Rule OUT Tests (Sensitivity > 90%) EACH NEGATIVE TEST Scores − 1 (Positive Rule OUT Test Score 0)




Alpha-defensin immunoassay (>5.2 mg/L)
Imaging 99mTc bone scan
Rule IN Tests (Specificity > 90%) EACH POSITIVE TEST Scores + 1 (Negative Rule IN Test Score 0)









Alpha-defensin immunoassay (>5.2 mg/L) or lateral flow test
Imaging Radio-labelled leukocyte scintigraphy (if necessary, with combined bone marrow scintigraphy)
Histology Frozen section (5 neutrophils in at least 3 HPFs)
Abbreviations: BIM: biofilm-related implant malfunction; LG-PJI: low-grade peri-prosthetic joint infection; HG-PJI: high-grade peri-prosthetic joint infection. ESR: erythrocyte
sedimentation rate; CRP: C-reactive protein; IL-6: interleukin-6; WBC: white blood cell count; PC: procalcitonin; LE: leukocyte esterase strip (++); HPFs: high power fields (400×);
99mTc: 99 metastable Technetium.
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These six definitions differ greatly in their diagnostic criteria, scoring systems and reference
values (Tables 1 and 2), while even the most complex scores may result as “inconclusive” in a given
patient [10]. Of note, with the exception of the WAIOT’s definition, all other proposed definitions of
PJI include only a selection of diagnostic tests while systematically excluding any role of imaging,
in spite of their reported diagnostic value (Table 2) [14]. In doing so, none of them provide a clear
scientific explanation for this exclusion, while on the other hand, it is a common observation that most
clinicians do prescribe some imaging investigations when dealing with a (suspected case of) PJI. In this
complex panorama, to further understand the role of imaging techniques in the diagnostic protocol of
peri-prosthetic joint infections, a multidisciplinary group met from December 9 to 12, 2019 in Rome,
during the Third European Congress on Inflammation/Infection Imaging.
The results of the discussions, held during those days and thereafter through online consultations,
are reported here in the form of clinical questions with consensus answers. These are also based
on the previously published Italian Guidelines to Diagnose Peri-Prosthetic Joint Infections [15] and
joint European guidelines on PJI published by European Association of Nuclear Medicine (EANM),
European Bone and Joint Infection Society (EBJIS) and European Society of Radiology (ESR), with the
endorsement of European Society of Clinical Microbiology and Infectious Disease (ESCMID) [14,16],
to which we refer that contain details about all imaging modalities.
2. Assessment Parameters of Peri-Prosthetic Joint According to PJI Definitions
Current PJI definitions rely on four diagnostic classes of investigations: (1) clinical presentation,
(2) serum and synovial markers, (3) imaging techniques and (4) microbiological and histological
findings (Tables 1 and 2).
Concerning clinical presentation, the presence of a draining sinus or of an exposed implant is
considered as pathognomonic or highly specific by all the available definitions [7–12]. However,
this sign may be totally absent in more than 70% of peri-prosthetic joint infections, thus featuring a
quite low sensitivity [17].
Serum and synovial fluid markers are variably included in all the available PJI definitions,
apart from the one released by IDSA, while the proposed EBJIS definition only considers synovial
leukocyte cell count. No single biomarker has been shown to be 100% accurate in diagnosing PJI,
and therefore all definitions introduced a scoring system based on combining the results of different
tests. These scoring systems not only vary greatly among the definitions, but also differ in cut-off values
that are chosen for the various definitions, which limits their comparability. Furthermore, most of
the definition systems acknowledge the fact that serum and synovial biomarkers results should be
interpreted with caution within the first three months after surgery and in patients under antibiotic
treatment or patients with concomitant systemic inflammatory diseases.
Concerning imaging, no available PJI definition includes any of these investigations, except for
the recently released WAIOT definition (Table 2).
The WAIOT definition, validated in a large clinical, multi-institutional and international trial [13],
includes only two imaging techniques, 99metastable Technetium (99mTc)-bone scan and 99mTc-leukocyte
scan, chosen according to the available literature, respectively as a ‘rule out’ and ‘rule in’ test to
define PJI. In this regard, it should be noted that the WAIOT definition provides a set of rule out
and rule in tests, among which the clinician is left free to choose. The final definition is based
on the relative balance of positive rule in tests and negative rule out tests. Microbiological and
histological findings are considered relevant investigations by all the available definitions to confirm
PJI. More specifically, positive cultures, even if criteria and recommendations vary across definitions,
are considered pathognomonic by all of the classification systems examined in Tables 1 and 2. However,
limitations do apply with regard to the interpretation of a single positive culture and for suboptimal
procedural investigations. In fact, falsely negative cultures are reported in approximately 20% of
PJIs, according to a recent review [18]. Therefore, microbiological sampling, transport and processing
should be performed according to the best available microbiological standards, which includes the
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preparation of four to six peri-prosthetic tissue cultures and the analysis of the removed implant,
transported in closed systems processing with antibiofilm techniques (sonication or dithiothreitol) and
with prolonged cultures. In selected cases, genomic pathogen identification may also be advisable [19].
Similarly, histology is ranked among the most specific examinations to differentiate a PJI from
other causes and is highly scored or plays a confirmatory role in five out of six of the examined PJI
definitions, even if its sensitivity may by be as low as 57% and it may be prone to interpretation bias,
according to the experience of the pathologist [20].
3. Conventional Techniques for Diagnosis of PJI
The first diagnostic imaging modality is generally conventional radiography.
X-ray examinations are the standard examination to perform after arthroplasty and for follow-up
to assess the presence of displacement, mobilization of the implant components, periprosthetic bone
resorption and other causes of pain.
However, diagnostic performance of conventional radiography in detecting PJI is very low.
Furthermore, conventional radiography may show demineralization only when more than 30–50% of
bone mass has been lost, and abnormalities of bone around the implant are usually non-specific for
infection. In addition, up to 50% of conventional X-ray exams give negative results.
Regarding ultrasound (US), disputable results have been reported for the detection of PJI.
US may be used to guide aspiration procedures of infectious materials in PJI and can be effectively
used to evaluate peri-prosthetic fluid collections, attempting to differentiate abscesses from aseptic
collections [21], and to track the presence of sinus tracts within soft tissues. The main advantages of US
are its wide availability, low cost, the possibility to perform it bedside and repeated imaging without
radiation burden [21].
Computed tomography (CT) has been reported to have a good diagnostic performance in the
detection of PJI, with accuracy of up to 84% (Figure 1). CT is also the imaging modality of choice
perform image-guided bone biopsies [22].
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the presence of periosteal reaction, capsule edema, and intramuscular edema has a high accuracy for
evaluating PJI [23], (Figure 2). Similar to US, MRI has the advantage of not using ionizing radiation or
contrast agents [24–26].
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Figure 2. Magnetic resonance imaging (MRI) of a 58-year-old patient with culture-proven infected
right hip prosthesis. (A) T2-weighted axial and (B) short-tau inversion recovery coronal scan show
hyperintense synovitis (asterisks), extra-capsular edema (arrows), and bone edema (circles). Metallic
artefact is limited to the implant only (P) and does not obscure the findings of infection.
Both CT and MRI may be useful to document the extent of bone lesions as well as abnormalities
in the articular space and, therefore, they may help the surgeon in planning the most appropriate
strategy. Moreover, US and CT are extremely useful for performing (when feasible) fluid aspirations,
thus representing an important tool in the diagnostic work-up of PJI.
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4. Nuclear Medicine Techniques for Diagnosis of PJI
Several imaging techniques can be used to evaluate PJI including bone scintigraphy, radio-labelled
white blood cell (WBC) scintigraphy (with or without combined bone marrow scintigraphy),
anti-granulocyte antibody scintigraphy, and fluorodeoxyglucose positron emission tomography
([18F]-FDG-PET).
Both planar and tomographic acquisitions, with single photon emission tomography (SPECT),
can be performed and the use of hybrid modalities such as SPECT/CT or PET/CT increases the
diagnostic accuracy in terms of the exact location and extent of the infectious process. Importantly,
scintigraphic techniques by gamma camera are not affected by metallic hardware; PET/CT may present
some artefacts.
4.1. Bone Scintigraphy
Bone scintigraphy is usually performed after the injection of 99mTc-labelled diphosphonates and a
three-phase bone scintigraphy can be performed to assess early perfusion, diffusion, and late bone
uptake. The uptake of these tracers is usually related to bone remodelling. After a prosthetic implant,
the periprosthetic bone is obviously damaged and a remodelling process will occur in the months
following surgery.
This remodelling process is more evident for bio-inductive prostheses compared to cemented
prostheses. The main advantage of bone scintigraphy is its very high sensitivity (when negative, it rules
out an infection with high certainty), but this method is accompanied by a low specificity for PJI.
Conversely, this method may be able to detect bone abnormalities in case of prosthetic mobilization,
particularly if a hybrid SPECT/CT technique is used. Recently, the EANM Bone and Joint Committee
has published procedural guidelines on how to perform this modality best for each pathology [27].
4.2. White Blood Cell Scintigraphy
WBCs can be labelled with 99mTc- hexamethylene-propyleneamine oxime (HMPAO) (Figure 3) or
111In-oxine (Figure 4). The labelling method, image acquisition and interpretation are regulated by
several national rules and guidelines [28–30].
Taking into account the different biodistribution and kinetics of radio-labelled WBCs in blood,
bone-marrow, infection and sterile inflammation, images should be acquired at three different
time points with decay time-corrected acquisition: “early images” (within 30 min and 1 h after
radiopharmaceutical injection), “delayed images” (between 2 h and 4 h after radiopharmaceutical
injection) and “late images” (between 20 h and 24 h after radiopharmaceutical injection). Even though
the diagnosis of a PJI is made on planar images (increase in uptake or size between the delayed images
at 3–4 h and the late images at 20–24 h), tomographic images are recommended in case of positive planar
images to assess the exact location and extent of the infectious process. Using these image acquisition
parameters and interpretation criteria, this technique reaches a high sensitivity and specificity, as a
recent multicenter study has shown [31]. The overall diagnostic accuracy of this technique exceeds
90% for PJI and this method constitutes the gold standard imaging technique for diagnosing PJI.
4.3. Anti-Granulocyte Antibody Scintigraphy
99mTc-labelled monoclonal antibodies (mAbs) may be used as an alternative to WBC scintigraphy
to evaluate PJI. Besilesomab is a full size anti-granulocyte mAb produced in murine cells and designed
to attach to the non-specific cross-reacting antigen (NCA)-95 antigen localized on the surface of
granulocytes. Sulesomab is an antigen-binding mAb fragment designed to target the NCA-90 antigen
on the surface of granulocytes. For radio-labelled mAbs, imaging protocols differ between complete
and fragmented antibodies [32]. The acquisition protocol for full length antibodies (Besilesomab)
is similar to WBC scintigraphy. The best time point for SPECT images is at 16–24 h post injection,
similarly to WBC, but an early scan can also be performed if required.
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4.4. Bone Marrow Scintigraphy
Bone marrow scintigraphy is usually recommended in addition to WBC scintigraphy in equivocal
cases. The radiopharmaceutical used is 99mTc-colloids (colloids greater than 500 nm) that enables
visualization of the bone marrow (thus distinguishing expanded bone marrow from sites of leukocyte
accumulation). About 185 MBq of 99mTc-colloids are intravenously injected and planar scintigraphic
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images of the region of interest are usually acquired after a minimum of 20–30 min and a maximum of
6 h post injection [30]. Concordant findings between both techniques rule out an infectious process
while discordant findings (uptake on WBC scintigraphy without corresponding uptake on bone marrow
scintigraphy) are highly suggestive of an infection.
4.5. FDG PET/CT
Although [18F]-FDG-PET/CT offers several advantages over WBC scintigraphy (more convenient
for the patient, no need for cell labeling, whole procedure takes less than 2 h), looking at the available
published data so far, it is unclear whether [18F]-FDG-PET may offer significant advantages over
radio-labelled WBC or anti-granulocyte monoclonal antibodies for the evaluation of PJI [33,34].
Different interpretation criteria for PJI have been proposed by Reinartz et al. [35], Chacko et al. [36],
Love et al. [37], Familiari et al. [38] and Stumpe et al. [39], but all these studies led to an overall accuracy
of <90% with conflicting results amongst studies [40,41]. In any case, visual interpretation is generally
more reliable than quantitative (SUV) analysis, which is currently not recommended (Figure 5).
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Figure 5. Prosthetic joint infection detected by 18Fluorine-fluorodeoxyglucose positron emission
tomography/computed tomography ([18F]-FDG-PET/CT) in a 72-year-old male patient who underwent
left hip arthroplasty four years before the PET/CT scan. [18F]-FDG-PET/CT images (A: axial view of
CT scan; B: axail fused images; C: axial PET images; D: coronal [18F]-FDG-PET/CT view; E: sagittal
[18F]-FDG-PET/CT view; F: maximum intensity projection [18F]-FDG-PET images) showed increased
radiopharmaceutical uptake in the periprosthetic bone and soft tissues at the level of the femoral
component of the prosthesis. These findings were indicative of prosthetic joint infection, which was
confirmed by further examinations including microbiological culture.
4.6. Hybrid Imaging Techniques
Hybrid imaging modalities combining functional and anatomical data have significantly increased
the accuracy of conventional nuclear medicine modalities by reducing the number of doubtful cases.
J. Clin. Med. 2020, 9, 2548 11 of 20
The hybrid imaging approach leads to a more accurate assessment of both localization (soft tissue vs.
bone vs. both) and disease extent.
SPECT/CT is nowadays often performed as an integral part of a conventional WBC/mAb
scintigraphy in order to better localize the uptake into bone or soft tissues and to accurately assess
the extent of the infection [42–46]. [18F]-FDG-PET/CT can be considered as a first-line diagnostic tool
for evaluating patients with inflammatory diseases and/or fever of unknown origin, according to
evidence-based data [41]; in cases of spondylodiscitis and fungal infections, its role has also been
well described.
More recently, the introduction of PET/MRI has emerged as a powerful diagnostic tool, but its
value in PJI has not been systematically addressed. The general advantages of MRI compared to CT
include a better evaluation of soft tissue and a lack of radiation burden. In addition, MRI sequences
that avoid artefacts from metallic implants are now widely available [23–26,47–51].
Finally, it is worth mentioning that one should always keep in mind that the final decision for a
particular imaging technique will be highly dependent on the local availability, time, cost and expertise.
5. Clinical Questions and Consensus Answers
At the Third European Congress on Inflammation/Infection Imaging, held in Rome on December
2019, there were several sessions dedicated to radiological and nuclear medicine imaging of prosthetic
joint infections. The round table discussions, with clinicians and specialists in infective disease,
were very much animated in particular with regard to the role of CT vs. MRI and FDG-PET/CT
vs. radio-labelled WBC. Below are the main points raised by orthopedic surgeons and the answers
provided by radiologists and nuclear medicine physicians.
5.1. What Is the Role of Conventional X-ray to Diagnose a PJI?
There is no role of plain films for differential diagnosis of PJI. Nevertheless, an X-ray image can
be very useful to evaluate other concomitant problems, the degree of loosening, bone reabsorption,
fractures, etc. that may all help for the interpretation of images obtained by other modalities, particularly
non-radiological modalities [52]. For this reason, conventional radiography remains the first imaging
modality in patients with suspected PJI and for their follow-up [14].
5.2. What Is the Role of Ultrasound to Diagnose a PJI?
Data on the use of US to diagnose PJI are scarce and conflicting [14]. At present, US is mostly
used to guide joint aspiration or biopsy to perform microbial culture [21].
5.3. What Is the Role of CT to Diagnose a PJI?
Whenever CT is used to diagnose a PJI, artefacts caused by the interaction between X-ray beams
and metallic hardware should be reduced by suitable software and techniques [16]. Joint capsule
distension and the presence of fluid collections in the soft tissues surrounding a hip implant showed
100% sensitivity, 87% specificity, and 89% accuracy when at least one soft tissue abnormality was used
as an infection criterion, and 83% sensitivity, 96% specificity, and 94% accuracy when joint distension
was used as infection criterion [22]. CT may be used to more effectively diagnose bone resorption
and bone lucency around the implant compared to plain films, however this may not be considered a
reliable parameter to differentiate between infection and other reasons for implant failure [22]. CT is
useful for guiding biopsies and fluid aspiration.
5.4. What Is the Role of MRI to Diagnose a PJI?
The advent of prostheses made with less ferromagnetic alloy materials and the introduction of
metal artefact reduction sequences (MARS), slice encoding for metal artefact correction (SEMAC),
and multi-acquisition with variable-resonance image combination (MAVRIC) has pave the way for
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the use of MRI in patients with joint prosthesis, limiting the artefacts to the area of the implant
itself. However, published data about the role of MRI to diagnose PJI are still very limited. In knee
implants, the sensitivity and specificity of MRI in diagnosing PJI range from 65% to 92% and 85% to
99%, respectively [14]. Similarly, in the hip, the presence of periosteal reaction, capsule edema, and
intramuscular edema demonstrated a sensitivity ranging from 78% to 95% and a specificity from 86%
to 97%, depending on the signs that are considered for the diagnosis [23,50]. MRI also has the great
advantage of not using ionizing radiation or contrast agents [24–26]. MRI may be limited by patient
claustrophobia or the presence of an implanted non-MR compatible device.
5.5. What Is the Role of Three-Phase Bone Scan to Diagnose a PJI (Is a Negative Scan Sufficient to
Exclude a PJI)?
Three-phases (perfusion, blood pool, osteometabolic phase) are necessary to perform a 99mTc bone
scan in suspected PJI. A positive bone scan may be observed in many conditions characterized by
increased osteoblast activity, and therefore it is not specific for infection; a negative scan in all three
phases means that there is no increased perfusion and no increased osteoblastic activity. Given its
high negative predictive value (NPV), a negative three-phase bone scan is sufficient to rule out
infection [14,53].
5.6. What Is the Minimum Time Window between the Date of Surgery and a Three-Phase Bone Scan to
Diagnose a PJI?
Within the first year after hip arthroplasty, periprosthetic uptake patterns are variable depending
on the type of surgery and device [54]. For cemented hip arthroplasties, the majority of asymptomatic
patients have a normal bone scan, but up to 10% will have persistent periprosthetic uptake after
one year from implantation. For porous-coated hip arthroplasties, persistent uptake beyond one
year is even more frequent. Furthermore, few data are available about the longitudinal evolution of
normal periprosthetic uptake patterns around hybrid, bipolar, and hydroxyapatite-coated devices.
Periprosthetic activity around knee arthroplasties in asymptomatic patients is present in more than 50%
of femoral components and nearly 90% of tibial components more than one year following implantation.
Although periprosthetic activity usually becomes milder over time, there is considerable variation
among patients and therefore serial scans should be performed [55]. Since it is not possible to clearly
define a date, it has been suggested that positive bone scans should be interpreted with caution for a
period of two years from surgery for hip and shoulder prosthesis and a period of five years for knee
prosthesis. On the other hand, it can be postulated that a negative bone scan virtually excludes a PJI
even within the above reported time windows [53].
5.7. What Is the Role of a WBC Scan to Diagnose a PJI (Is a Negative Scan Sufficient to Exclude a PJI)?
Several systematic reviews and meta-analyses have been published indicating that WBC scans—if
necessary, combined with a bone marrow scan—have very high specificity for identifying peri-prosthetic
joint infection versus aseptic loosening [55–60], thus representing the most reliable imaging tool able
to achieve this differentiation. The reported accuracy of the use of combined WBC scintigraphy
(using either 99mTc-HMPAO-WBC or 111In-oxine-WBC) and bone marrow scintigraphy ranges from
83% to 98% for both hip and knee prosthesis infections [34].
Expert opinions and most research studies indicate a high NPV for WBC scintigraphy. This could
be even higher if the correct acquisition protocols and interpretation criteria are applied [30]. In fact,
NPVs ranging from 92% to 100% have been reported in the largest and most recent studies. [31,56].
Therefore, we can conclude that a negative WBC is sufficient to exclude a PJI.
5.8. What Is the Role of [18F]-FDG-PET/CT to Diagnose a PJI (Is a Negative Scan Sufficient to Exclude a PJI)?
While there is considerable debate about the specificity of [18F]-FDG, most investigators agree
that the test is very sensitive and therefore the negative predictive value is high [54,61,62]. In an
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investigation of 21 patients with suspected PJI of the knee, [18F]-FDG-PET was 100% sensitive, but only
73% specific for infection [63]. In a recent investigation in 130 patients with suspected PJI of the hip,
with final diagnosis based on the criteria recommended by the MSIS, [18F]-FDG-PET/CT yielded a
sensitivity and specificity of 95% and 39%, respectively, for infection [64]. Based on the available
literature, it seems reasonable to conclude that a negative result effectively excludes PJI. Whether or
not [18F]-FDG is superior to bone scintigraphy for excluding infection is not answerable with currently
available data.
5.9. What Is the Spatial Resolution of Currently Available Imaging Techniques in Order to Describe the Extent
of a PJI?
The spatial resolution of a planar WBC scan is approximately 0.8–1 cm and by SPECT, the spatial
resolution is 0.5–0.6 cm. The newest digital PET/CT scanners can reach resolutions as low as 2–3 mm.
Morphological examinations such as CT and MRI have much higher special resolution as compared
to nuclear medicine modalities.
However, available imaging techniques only reflect the extent of the host’s response,
i.e., the inflammatory process, or describe morphological changes due to the interaction between the
pathogen and the host. This does not necessarily reflect the extent of the infection. Accurate delineation
of the extent of the infection around an implant would require an infection-specific imaging technique,
which is currently lacking.
5.10. Can Clinicians Rely on a Scan to Decide to Maintain a Component of an Implant If Infection Is Ruled Out
by Imaging Investigations?
If imaging modalities (radiological and/or nuclear medicine) exclude the presence of infection,
clinicians can decide to maintain one or all components of the prosthesis mainly because all imaging
modalities have very high sensitivity. In these cases, a component should be removed based on the
degree of loosening and patient compliance. On the other hand, if an infection is suspected by imaging,
to the best of our knowledge, there are no published data suggesting that infection can be limited to an
individual component of an arthroplasty and that this can be reliably assessed by an imaging modality.
5.11. Is There Any Evidence That Imaging Techniques May Have Different Accuracy or Thresholds to Diagnose
High-Grade and Low-Grade Peri-Prosthetic Joint Infections?
There are no comparative studies investigating the accuracy of imaging techniques in
patients with high-grade, acute peri-prosthetic infections versus low-grade, sub-acute or chronic
clinical presentations.
Nuclear imaging has been shown to be effective at differentiating chronic low-grade infection in
painful knee prostheses with a sensitivity and specificity of 71% and 95%, respectively, for combined
WBC/bone marrow scintigraphy [53].
However, the sensitivity of nuclear imaging techniques can be significantly reduced in low-grade,
chronic PJI of the shoulder. In fact, remarkably poor sensitivity of both [18F]-FDG and combined
labelled leukocyte/marrow imaging to diagnose chronic, low-grade periprosthetic shoulder infection
has been reported, with respective values of 14% and 18% [65,66]. Since there are no data on “high
grade” shoulder arthroplasty infections, it is impossible to determine if these results are related to the
chronic/low grade presentation of PJI or if it is just a specific feature of shoulder PJI.
5.12. Are There Any Studies Comparing Intra-Operative Histological Findings and/or Microbiological
Examination with Imaging Investigations?
In most investigations, final diagnoses are based on histopathology/microbiology. Overall,
these studies have been summarized in several systematic reviews and were considered for preparing
“evidence based guidelines” by EANM [14,16,30].
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5.13. Is It Necessary to Stop Antibiotic Treatment before Performing a Scan to Diagnose a PJI?
It is not necessary to discontinue antibiotic treatment for a CT or MRI scan, neither for a bone
scintigraphy or FDG-PET/CT. In contrast, it is believed that antimicrobial treatment may reduce the
diagnostic accuracy of WBC scintigraphy, probably because of decreased number and activity of
bacteria, which reduces the release of chemotactic factors, hence the accumulation of WBC at the site of
infection over time. This accumulation over time is the physio-pathological principle on which the
interpretation of WBC images is based.
However, there are only two studies in PJI [67,68] and one study in fracture-related infections
using radio-labelled WBC [69] that show no differences in diagnostic accuracy between patients under
antibiotics vs. antibiotic discontinuation. To the best of our knowledge, there is currently no data
available on the impact of antibiotic treatment on the diagnostic performance of FDG-PET/CT in PJI.
5.14. What Are the Most Promising Technologies Currently under Investigation to Diagnose PJI and Other
Implant-Related Infections?
Given the challenges in diagnosing PJI, an infection-specific agent would be very valuable.
To achieve this aim, several attempts have been made using a variety of approaches including
radio-labelled antibiotics, vitamins, sugars and peptides [70,71].
5.15. Should Nuclear Medicine Imaging Techniques Be Included in the Definition of Peri-Prosthetic Joint
Infection and, in Case of a Positive Answer, Which One Would You Recommend?
Nuclear medicine imaging techniques should be included in the modern definition of PJI. In fact,
these diagnostic tools, if adequately performed, provide an overall accuracy that can be considered
similar to that of other commonly accepted examinations, or even better.
Unfortunately, despite several systematic reviews, meta-analyses and single studies, some clearly
indicate that WBC scans—combined or not with bone marrow scans—are the most reliable imaging
tool for identifying peri-prosthetic joint infection. Others suggest the use of FDG-PET or radio-labelled
anti-granulocyte antibodies, or even bone scans [34,53,56,61,65,67,72–84]. This needs to be clarified.
There is a considerable variation in results when looking at individual studies due to different labelling
methods, image acquisition protocols, image interpretation, patient selection, etc. Furthermore,
most systematic reviews do not include all published studies, nor a set time interval for paper selection.
As a result, in some “systematic reviews” we find as little as three, or even two or just one, paper(s) on
nuclear medicine modalities. In other meta-analyses, there are often a mixture of very old papers with
very recent ones using completely different methodologies. Unfortunately, no recent large multicenter
prospective multimodal comparative studies with standardized image acquisition and interpretation
parameters exist, and therefore we cannot provide a firm evidence-based conclusion with regard to the
imaging modality of choice for PJI.
Despite this, some practical considerations can be made. Indeed, in clinical practice, the choice
of imaging modality will highly depend on local availability, waiting lists, patient claustrophobia,
metal devices, operator experience and cost (which is country dependent). FDG costs approximately
150 €, takes approximately 2 h to perform, the waiting list is approximately 1–2 weeks, costs for
the National Health Service (NHS) are approximately 1200 €, the radiation dose for the patient is
approximately 6–8 mSv and the overall diagnostic accuracy for PJI ranges from 65% to 90%. A WBC
scan (or anti-granulocyte antibodies) costs approximately 150 €, takes approximately 2 h for labelling
(the patient is busy from 8:00 am to 3:00 pm on the first day and from 8:00 am to 9:00 am the following
day), the waiting list is approximately 1–3 weeks, the cost for the NHS is approximately 450–1000 €,
the radiation dose for the patient is approximately 5 mSv and the overall diagnostic accuracy for PJI
ranges from 70% to 95%.
It emerges that there are pros and cons for both modalities. If we require a very urgent screening
test, particularly in patients with a low pre-test probability of infection, we can perform a bone scan or
FDG (both able to effectively rule-out a PJI when negative, but could show residual inflammation for a
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long time after surgery) [53,54,85–87]. If we know upfront that there is a high suspicion of infection,
or if we do not know if there is an infection or an aseptic loosening, it is preferable to perform a WBC
scan [14,16,30,88,89].
6. Conclusions
Several definitions of PJI exist, but the use of imaging modalities is lacking in most of these
scoring systems.
In this manuscript, we focused on the current role of several different imaging techniques in
order to understand if this exclusion is justified in light of their possible contribution to diagnose a
peri-prosthetic infection.
The panel highlighted how several imaging techniques, their limits notwithstanding, may play a
key role in PJI definition.
While X-ray examinations may currently be regarded as a general screening for patients with
joint replacement, MRI and nuclear imaging techniques are much more specifically concerned with the
differential diagnostic work-up of PJI.
Based on available data in the literature, three-phase bone scans, WBC scans and FDG-PET scans
are all highly sensitive investigations; whenever negative, they can all be reliably considered as a
criteria to exclude a PJI. Furthermore, a positive WBC scan (if necessary, combined with a bone marrow
scan), is to be considered a confirmative criteria of PJI.
Concerning FDG-PET/CT, there is a need to establish clear and standardized interpretation criteria
to differentiate infection from non-infectious pathologies, especially aseptic loosening.
Finally, although very promising and attractive for its preliminary results, easy accessibility and
lack of ionizing radiation, MRI appears to be a potential important player; if further studies confirm its
accuracy in diagnosing PJI, it may be another imaging modality that will need to be included in the
upcoming PJI definitions.
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